PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Braun Medical, Inc.

Marketing 52

Marketing Education Media Healthcare 52

European Pharmaceutical Review

NOVEMBER 11, 2022

AHF is a major contributor to morbidity and mortality for heart failure patients. Patients admitted for acute heart failure are at high risk of readmission and death, especially in the first months after discharge. The trial evaluated the safety, tolerability and efficacy of NTLA-2001 in 12 participants.

Safety 99

Safety Medical Patients Transportation 99

PM360

OCTOBER 18, 2023

Avalere Health is purposefully built to be the leading, global commercialization partner for changemaking healthcare companies looking to maximize the value of their portfolios while connecting patients to life-changing health solutions. Healthcare is fragmented, preventing patients from accessing life-enhancing innovations quickly.

Healthcare 52

Healthcare Healthcare Consulting Marketing 52

Pharmaceutical Technology

FEBRUARY 13, 2023

The first concept for a PROTAC was published in 2001, and recently these protein degraders have gained rapid momentum as a promising novel modality. This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active.

Competition 59

Competition Safety Patients Pharmaceutical 59

European Pharmaceutical Review

SEPTEMBER 14, 2023

In 2001 and 2007, through 2009, the economy was hit hard. Therefore, it is best to collaborate with leading experts and scientists you can trust with your molecule. About the author Brandon Fincher is President of Early Stage Development & Testing at Cambrex, a leading global CDMO.

Manufacturing 80

Manufacturing Engineering Management Pharmaceutical 80

CloserIQ

OCTOBER 10, 2018

They’ve worked with leading clients such as Twitter and Mercedes Benz. Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Founded 2001. Founded 2007. 501-1000 employees. million in funding. See open roles. million in funding.

Sales 76

Sales Management Education Marketing 76

European Pharmaceutical Review

JULY 20, 2023

Background on BCT legislation in the EU Every year EU patients are treated with 25 million blood transfusions, a million cycles of medically assisted reproduction, over 35,000 transplants of stem cells and hundreds of thousands of replacement tissues.

Safety 62

Safety Distribution Food Medical 62

Cadensee

JULY 5, 2021

And specifically, when I was exposed to the issue of pain, helping patients suffer less from pain or from the pain treatment for me, was a good and still is a great mission. And one physician told me that, asking a patient what his pain level is like asking the patient what his blood pressure level. It took some time.

Physicians 52

Physicians Medical Patients Management 52

World of DTC Marketing

DECEMBER 30, 2020

This leads to obesity. By 2001, the amount rose to 11%. Just by decreasing 5% of sugar intake, individuals were witnessed to lose an average of 0.80kg of their body weight. And by increasing sugar intake by 5%, individuals were seen to gain an average of 0.75kg. (BMJ BMJ Research). It is estimated that $190.2

Government 181

Government Food Healthcare Healthcare 181

Pharmaceutical Technology

FEBRUARY 20, 2023

This may lead to therapies and dosing regimes being less suitable for minority populations – and according to Hans Bunschoten, chief strategy officer at clinical research company Cerba Research, part of Cerba Healthcare, this is a major problem. Hans Bunschoten: Viroclinics was founded in 2001, spun out of a university setting.

Healthcare 52

Healthcare Healthcare Medicine Biopharma 52

Pharmaceutical Technology

FEBRUARY 23, 2023

Many compounds present sub-optimal pharmacokinetic (PK) data (either predicted from in-vitro and pre-clinical data or measured in the clinic), such as poor exposure (leading to high doses), large variability, short half-life requiring more than once-a-day dosing, or C max -related adverse events (AEs). S54 – S61 (2001). Grass and P.

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical Food Side effects 98